These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35740164)

  • 1. Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools.
    Weinelt FA; Stegemann MS; Theloe A; Pfäfflin F; Achterberg S; Weber F; Dübel L; Mikolajewska A; Uhrig A; Kiessling P; Huisinga W; Michelet R; Hennig S; Kloft C
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study.
    Areskog Lejbman I; Torisson G; Resman F; Sjövall F
    Acta Anaesthesiol Scand; 2024 Apr; 68(4):530-537. PubMed ID: 38407447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population - A prospective, multi-center, observational study (BLAST 1).
    Chua NG; Loo L; Hee DKH; Lim TP; Ng TM; Hoo GSR; Soong JL; Ong JCL; Tang SSL; Zhou YP; Lee W; Lee LS; Cove M; Ling LM; Kwa AL
    J Crit Care; 2022 Apr; 68():107-113. PubMed ID: 34999376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E; Padullés-Zamora A; Maisterra-Santos K; Colom-Codina H; Cobo-Sacristán S
    Farm Hosp; 2019 Sep; 43(5):151-157. PubMed ID: 31469627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
    Carlier M; Carrette S; Roberts JA; Stove V; Verstraete A; Hoste E; Depuydt P; Decruyenaere J; Lipman J; Wallis SC; De Waele JJ
    Crit Care; 2013 May; 17(3):R84. PubMed ID: 23642005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
    Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C
    Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?
    Esteve-Pitarch E; Gumucio-Sanguino VD; Cobo-Sacristán S; Shaw E; Maisterra-Santos K; Sabater-Riera J; Pérez-Fernandez XL; Rigo-Bonnin R; Tubau-Quintano F; Carratalà J; Colom-Codina H; Padullés-Zamora A
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):527-538. PubMed ID: 34131869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP.
    Gatti M; Rinaldi M; Tonetti T; Siniscalchi A; Viale P; Pea F
    Antibiotics (Basel); 2024 Mar; 13(4):. PubMed ID: 38666972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections.
    Berrino PM; Gatti M; Rinaldi M; Brunocilla E; Viale P; Pea F
    Antibiotics (Basel); 2023 Aug; 12(9):. PubMed ID: 37760685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented or Suspected Gram-Negative Infections.
    Gatti M; Rinaldi M; Laici C; Siniscalchi A; Viale P; Pea F
    Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF).
    Donnellan S; Wright DFB; Roberts JA; Duffull SB; Schollum JBW; Putt TL; Wallis SC; Walker RJ
    Eur J Clin Pharmacol; 2020 Feb; 76(2):239-247. PubMed ID: 31814045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study.
    De Corte T; Verhaeghe J; Dhaese S; Van Vooren S; Boelens J; G Verstraete A; Stove V; Ongenae F; De Bus L; Depuydt P; Van Hoecke S; J De Waele J
    Ann Intensive Care; 2023 Apr; 13(1):35. PubMed ID: 37119362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
    Sun HK; Kuti JL; Nicolau DP
    Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients.
    Heil EL; Nicolau DP; Farkas A; Roberts JA; Thom KA
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
    Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE
    Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020.
    Dräger S; von Rotz M; Labhardt ND; Siegemund M; Rentsch KM; Osthoff M; Franzeck FC
    Open Forum Infect Dis; 2023 Apr; 10(4):ofad143. PubMed ID: 37077503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study.
    Roberts JA; Joynt GM; Lee A; Choi G; Bellomo R; Kanji S; Mudaliar MY; Peake SL; Stephens D; Taccone FS; Ulldemolins M; Valkonen MM; Agbeve J; Baptista JP; Bekos V; Boidin C; Brinkmann A; Buizen L; Castro P; Cole CL; Creteur J; De Waele JJ; Deans R; Eastwood GM; Escobar L; Gomersall C; Gresham R; Jamal JA; Kluge S; König C; Koulouras VP; Lassig-Smith M; Laterre PF; Lei K; Leung P; Lefrant JY; Llauradó-Serra M; Martin-Loeches I; Mat Nor MB; Ostermann M; Parker SL; Rello J; Roberts DM; Roberts MS; Richards B; Rodríguez A; Roehr AC; Roger C; Seoane L; Sinnollareddy M; Sousa E; Soy D; Spring A; Starr T; Thomas J; Turnidge J; Wallis SC; Williams T; Wittebole X; Zikou XT; Paul SK; Lipman J;
    Clin Infect Dis; 2021 Apr; 72(8):1369-1378. PubMed ID: 32150603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
    Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational study.
    Zander J; Döbbeler G; Nagel D; Maier B; Scharf C; Huseyn-Zada M; Jung J; Frey L; Vogeser M; Zoller M
    Crit Care; 2016 Apr; 20():79. PubMed ID: 27039986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.